Cardinal Health CAH
$272.81 +$0.47 (+0.17%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $272.81 0.00%
Open$276.52
Prev close$272.34
Day range$271.98 – $277.72
Volume1.98M
Market cap$63.06B
P/E (TTM)35.3
Dividend yield0.75%
Fundamentals
Latest reported quarter: Q1, ended Sep 2026
Revenue$67.51B+5.5% YoY
Operating profit$819.00M+8.6% YoY
Net profit$556.00M+22.5% YoY
Diluted EPS$2.38+26.6% YoY
Free cash flow$1.24B+43.5% YoY
Operating cash flow$1.40B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin3.9%
Operating margin1.3%
Net margin0.7%
Return on assets3.2%
Current ratio0.88
Liabilities / assets104.8%
Cash & investments$5.26B
Total debt$8.82B
Net cash (debt)-$3.55B
Free cash flow / sales1.9%
Where the revenue comes from
Quarter 2027/Q1
By business line
SEC annual financial snapshot
Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-21 17:51 UTC.
| Metric | USD | Basis | Period end | Filed / SEC source |
|---|---|---|---|---|
| Revenue | $254.25B | Annual | 2026-06-30 | 2026-08-11 |
| Net income | $1.71B | Annual | 2026-06-30 | 2026-08-11 |
| Operating cash flow | $5.17B | Annual | 2026-06-30 | 2026-08-11 |
| Total assets | $57.30B | Period end | 2026-06-30 | 2026-08-11 |
| Stockholders’ equity | -$2.88B | Period end | 2026-06-30 | 2026-08-11 |
| Cash and cash equivalents | $4.86B | Period end | 2026-06-30 | 2026-08-11 |
Income statement
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $67.51B | $254.25B | $63.67B | $60.94B | $65.63B |
| Total Operating Revenue | $67.51B | $254.25B | $63.67B | $60.94B | $65.63B |
| Cost of Revenue | $64.92B | $244.47B | $61.11B | $58.44B | $63.23B |
| Gross Profit | $2.60B | $9.77B | $2.56B | $2.50B | $2.40B |
| Operating Expense | $1.78B | $6.60B | $1.75B | $1.66B | $1.63B |
| Selling and Admin Expenses | $1.60B | $6.13B | $1.63B | $1.54B | $1.50B |
| Depreciation & Amortization & Depletion | $182.00M | $469.00M | $121.00M | $114.00M | $130.00M |
| -Depreciation & Amortization | $182.00M | $469.00M | $121.00M | $114.00M | $130.00M |
| Operating Profit | $819.00M | $3.17B | $814.00M | $842.00M | $763.00M |
| Net Non-Operating Interest Income (Expense) | -$73.00M | -$348.00M | -$79.00M | -$101.00M | -$88.00M |
| Non-Operating Interest Expense | $73.00M | $348.00M | $79.00M | $101.00M | $88.00M |
| Other Income (Expense) | -$58.00M | -$651.00M | -$181.00M | -$349.00M | -$45.00M |
| Special Income (Charges) | -$64.00M | -$682.00M | -$207.00M | -$333.00M | -$56.00M |
| -Less:Restructuring and Mergern & Acquisition | $117.00M | $393.00M | $84.00M | $137.00M | $88.00M |
| -Less:Impairment of Capital Assets | -$4.00M | – | – | $185.00M | – |
| -Less:Other Special Charges | -$47.00M | -$10.00M | -$3.00M | $11.00M | -$18.00M |
| -Less:Write Off | -$2.00M | $299.00M | – | – | -$14.00M |
| Other Non-Operating Income (Expenses) | $6.00M | $31.00M | $26.00M | -$16.00M | $11.00M |
| Pretax Profit | $688.00M | $2.17B | $554.00M | $392.00M | $630.00M |
| Tax | $132.00M | $469.00M | $154.00M | $12.00M | $159.00M |
| Net Profit | $556.00M | $1.71B | $400.00M | $380.00M | $471.00M |
| Profit from Continuing Operations | $556.00M | $1.71B | $400.00M | $380.00M | $471.00M |
| Minority Interests | $2.00M | -$9.00M | $2.00M | -$19.00M | $4.00M |
| Net Income to Parent Company | $554.00M | $1.71B | $398.00M | $399.00M | $467.00M |
| Net Income to Common Stockholders | $554.00M | $1.71B | $398.00M | $399.00M | $467.00M |
| Basic EPS | $2.39 | $7.27 | $1.70 | $1.69 | $1.98 |
| Diluted EPS | $2.38 | $7.23 | $1.70 | $1.69 | $1.97 |
| Dividend Per Share | $0.52 | $2.05 | $0.52 | $0.51 | $0.51 |
Balance sheet
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Assets | $59.54B | $57.30B | $57.30B | $56.69B | $58.08B |
| Total Current Assets | $40.99B | $38.75B | $38.75B | $38.06B | $39.23B |
| Cash and Cash Equivalents & Short-Term Investments | $5.26B | $4.86B | $4.86B | $3.94B | $2.78B |
| -Cash and Cash Equivalents | $5.26B | $4.86B | $4.86B | $3.94B | $2.78B |
| Receivables | $14.54B | $13.82B | $13.82B | $13.65B | $13.66B |
| -Accounts Receivable | $14.54B | $13.82B | $13.82B | $13.65B | $13.66B |
| Inventory | $18.40B | $17.30B | $17.30B | $18.01B | $20.12B |
| Other Current Assets | $2.78B | $2.76B | $2.76B | $2.47B | $2.68B |
| Total Non-Current Assets | $18.55B | $18.55B | $18.55B | $18.63B | $18.85B |
| Net PPE | $3.00B | $3.03B | $3.03B | $2.93B | $2.88B |
| Goodwill and Other Intangible Assets | $13.69B | $13.63B | $13.63B | $13.70B | $13.98B |
| -Goodwill | $11.54B | $11.44B | $11.44B | $11.42B | $11.61B |
| -Other Intangible Assets | $2.15B | $2.19B | $2.19B | $2.28B | $2.37B |
| Other Non-Current Assets | $1.87B | $1.88B | $1.88B | $2.00B | $2.00B |
| Total Liabilities | $62.41B | $60.02B | $60.02B | $59.36B | $60.78B |
| Total Current Liabilities | $46.33B | $43.90B | $43.90B | $41.99B | $43.31B |
| Payables | $40.94B | $38.28B | $38.28B | $37.83B | $39.00B |
| -Accounts Payable | $40.94B | $38.28B | $38.28B | $37.83B | $39.00B |
| Current Accrued Expenses | $3.50B | $3.74B | $3.74B | $3.48B | $3.64B |
| Short-Term Debt and Capital Lease Obligation | $1.89B | $1.88B | $1.88B | $671.00M | $680.00M |
| -Current Debt | $1.89B | $1.88B | $1.88B | $671.00M | $680.00M |
| Total Non-Current Liabilities | $16.08B | $16.12B | $16.12B | $17.37B | $17.47B |
| Long Term Debt and Capital Lease Obligation | $6.93B | $7.00B | $7.00B | $8.25B | $8.35B |
| -Long Term Debt | $6.93B | $7.00B | $7.00B | $8.25B | $8.35B |
| Other Non-Current Liabilities | $9.16B | $9.12B | $9.12B | $9.13B | $9.12B |
| Total Equity | -$2.87B | -$2.72B | -$2.72B | -$2.67B | -$2.70B |
| Stockholders' Equity | -$3.03B | -$2.88B | -$2.88B | -$2.83B | -$2.88B |
| Capital Stock | $2.77B | $2.89B | $2.89B | $2.82B | $2.85B |
| -Common Stock | $2.77B | $2.89B | $2.89B | $2.82B | $2.85B |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained Earnings | $2.44B | $2.01B | $2.01B | $1.73B | $1.46B |
| Less: Treasury Stock | -$8.08B | -$7.61B | -$7.61B | -$7.22B | -$7.03B |
| Gains/Losses Not Affecting Retained Earnings | -$159.00M | -$165.00M | -$165.00M | -$161.00M | -$153.00M |
| Minority Interests | $159.00M | $159.00M | $159.00M | $160.00M | $184.00M |
| -Gross PPE | – | $7.97B | $7.97B | – | – |
| -Accumulated Depreciation | – | -$4.94B | -$4.94B | – | – |
Cash flow
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.40B | $5.17B | $1.69B | $1.82B | $686.00M |
| Net cash flow from continuing operations | $1.40B | $5.17B | $1.69B | $1.82B | $686.00M |
| Net Income from Continuing Operations | $556.00M | $1.71B | $400.00M | $380.00M | $471.00M |
| Depreciation & Depletion & Amortization | $247.00M | $956.00M | $241.00M | $248.00M | $234.00M |
| Change in Working Capital | $462.00M | $1.66B | $748.00M | $846.00M | -$106.00M |
| -Change in Receivables | -$734.00M | -$408.00M | -$193.00M | -$17.00M | $341.00M |
| -Change in Inventory | -$1.17B | -$488.00M | $697.00M | $2.09B | -$2.54B |
| -Change in Payables and Accrued Expense | $2.37B | $2.60B | $262.00M | -$1.23B | $2.10B |
| -Change in Other Current Liabilities | -$4.00M | -$45.00M | -$18.00M | -$5.00M | -$6.00M |
| Net cash flow from investing | -$251.00M | -$2.58B | -$281.00M | -$181.00M | -$1.98B |
| Net Cash Flow from Continuing Investing Activities | -$251.00M | -$2.58B | -$281.00M | -$181.00M | -$1.98B |
| Net PPE Purchase and Sale | -$142.00M | -$618.00M | -$264.00M | -$146.00M | -$100.00M |
| Net Business Purchase and Sale | -$149.00M | -$1.99B | -$24.00M | -$42.00M | -$1.88B |
| Net Investment Purchase and Sale | $34.00M | $28.00M | $1.00M | $27.00M | -$9.00M |
| Net Other Investing Changes | $6.00M | -$3.00M | $6.00M | -$20.00M | $13.00M |
| Financing Cash Flow | -$742.00M | -$1.60B | -$490.00M | -$483.00M | -$519.00M |
| Net Cash Flow from Continuing Financing Activities | -$742.00M | -$1.60B | -$490.00M | -$483.00M | -$519.00M |
| Net Issuance Payments Of Debt | -$11.00M | $337.00M | -$17.00M | -$111.00M | -$12.00M |
| Net Common Stock Issuance | -$500.00M | -$1.36B | -$350.00M | -$250.00M | -$383.00M |
| Cash Dividends Paid | -$126.00M | -$491.00M | -$120.00M | -$120.00M | -$122.00M |
| Net Other Financing Charges | -$105.00M | -$90.00M | -$3.00M | -$2.00M | -$2.00M |
| Ending Cash Balance | $5.26B | $4.86B | $4.86B | $3.94B | $2.78B |
| Net Change in Cash | $405.00M | $988.00M | $921.00M | $1.16B | -$1.81B |
| Beginning Cash Balance | $4.86B | $3.87B | $3.94B | $2.78B | $4.59B |
| Effect of Exchange Rate Changes | $3.00M | -$6.00M | -$2.00M | $1.00M | -$3.00M |
| Free Cash Flow | $1.24B | $4.53B | $1.43B | $1.68B | $555.00M |
| Deferred Tax | – | $91.00M | – | – | – |
No comments yet — be the first to weigh in on CAH.
Sign in to join the discussion.